Regeneron Pharmaceuticals, Inc. (LON:0R2M)
London flag London · Delayed Price · Currency is GBP · Price in USD
620.72
-11.27 (-1.78%)
At close: Apr 1, 2025

Regeneron Pharmaceuticals Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
51,08661,21773,32963,95348,76437,347
Upgrade
Market Cap Growth
-16.52%-16.52%14.66%31.15%30.57%20.50%
Upgrade
Enterprise Value
39,50248,77063,13155,41442,32434,998
Upgrade
Last Close Price
480.21562.97687.86590.61469.81356.36
Upgrade
PE Ratio
14.4917.3723.6317.768.1814.51
Upgrade
PS Ratio
5.405.407.126.334.116.00
Upgrade
PB Ratio
2.612.613.603.403.524.63
Upgrade
P/TBV Ratio
2.722.723.753.543.524.63
Upgrade
P/FCF Ratio
20.9120.9124.1017.4210.1125.45
Upgrade
P/OCF Ratio
17.3417.3420.3315.379.3219.48
Upgrade
EV/Sales Ratio
3.604.306.135.493.575.62
Upgrade
EV/EBITDA Ratio
10.9513.1917.2812.516.1812.25
Upgrade
EV/EBIT Ratio
12.3214.7319.0013.376.3713.04
Upgrade
EV/FCF Ratio
13.4916.6620.7515.098.7823.85
Upgrade
Debt / Equity Ratio
0.100.100.110.120.140.25
Upgrade
Debt / EBITDA Ratio
0.630.630.600.520.290.69
Upgrade
Debt / FCF Ratio
0.800.800.720.630.411.35
Upgrade
Asset Turnover
0.400.400.420.450.760.53
Upgrade
Inventory Turnover
2.512.512.512.372.742.26
Upgrade
Quick Ratio
3.863.864.824.162.982.86
Upgrade
Current Ratio
4.734.735.695.063.563.63
Upgrade
Return on Equity (ROE)
15.95%15.95%16.26%20.94%54.21%31.77%
Upgrade
Return on Assets (ROA)
7.31%7.31%8.49%11.42%26.39%14.33%
Upgrade
Return on Capital (ROIC)
8.49%8.49%9.76%13.31%31.95%17.95%
Upgrade
Return on Capital Employed (ROCE)
12.30%12.30%14.30%19.20%41.80%25.30%
Upgrade
Earnings Yield
6.90%5.76%4.23%5.63%12.23%6.89%
Upgrade
FCF Yield
5.73%4.78%4.15%5.74%9.89%3.93%
Upgrade
Buyback Yield / Dilution
-1.23%-1.23%-0.18%-1.16%2.52%-0.44%
Upgrade
Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.